Arick Wong

I lead clinical operations with a focus on scalability, quality, and speed-to-market. With 11 years of progressive experience spanning sponsor, CRO, and site-level roles across oncology, rare disease, infectious disease, CNS, and other indications, I bridge the gap between complex clinical development goals and high-performance operational reality. My career is defined by a "strategy-first" approach to Phase I-III trials, ensuring that global programs are not only compliant but optimized for cost and timeline efficiencies.- Strategic Versatility: I have steered trials across a massive range of indications—from high-science Oncology and Rare Disease to Cardiology and NASH.- High-Stakes Leadership: Expert at managing large-scale CROs and niche vendors, moving beyond "management" into true partnership and KPI optimization.- Regulatory & Quality Rigor: Expertise in ICH-GCP, global regulatory submissions, and ensuring "inspection-ready" quality for both drugs and IVD medical devices.Clinical Portfolio Highlights:- Oncology & Immunology: Extensive work in Solid & Liquid tumors (mesothelioma, NSCLC, Glioblastoma, Sarcoma, Leukemia/Lymphoma).- Advanced Modalities: Leading-edge research in Stem Cell Therapy (CAR-T, CAR-NK) and Psychedelic Therapeutics (PTSD/Eating Disorders).- Infectious Disease & Vaccines: Rapid-response trial management for HIV, RSV, and Influenza.- Specialized Research: Primary Mitochondrial Disease (Rare Disease), IVD Medical Devices, and Pain Management.I thrive in fast-paced environments where I can develop clinical teams, mitigate operational risks, and drive life-changing therapies toward approval.